Article
Parkinson’s disease causality and heterogeneity: a proteogenomic view
2022-03-12
Abstract excerpt
The pathogenesis and clinical heterogeneity of Parkinson’s disease have been evaluated from molecular, pathophysiological, and clinical perspectives. High-throughput proteomic analysis of CSF has opened new opportunities for scrutinizing this heterogeneity. To date, this is the most comprehensive CSF-based proteomics profiling study in Parkinson’s disease (1103 patients, 4135 proteins). Combining CSF aptamer-based...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d95696ac-1eed-5f7b-913c-8df69bf0319b
- DOI
- 10.1101/2022.03.09.22272131
